Modicus Prime

Modicus Prime’s mpVision platform enables real-time, GxP-compliant AI-driven image analysis to automate and enhance quality control in the manufacture of biologics, cell and gene therapies, and vaccines. The technology has been implemented by multiple global pharmaceutical manufacturers to reduce product failures due to contamination or process deviations. Early pilots demonstrated >99% accuracy in detecting contaminants such as silicon oil particles during production. The system aims to reduce industry-wide losses from failed batches—estimated at $25–50 billion annually—by enabling immediate corrective action during commercial production.